BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ooi PH, Hager A, Mazurak VC, Dajani K, Bhargava R, Gilmour SM, Mager DR. Sarcopenia in Chronic Liver Disease: Impact on Outcomes. Liver Transpl. 2019;25:1422-1438. [PMID: 31242345 DOI: 10.1002/lt.25591] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Whitsett M, Serper M. Exercise Interventions for Transplant Recipients. Curr Transpl Rep 2021;8:111-7. [DOI: 10.1007/s40472-021-00324-3] [Reference Citation Analysis]
2 Beer L, Bastati N, Ba-Ssalamah A, Pötter-Lang S, Lampichler K, Bican Y, Lauber D, Hodge J, Binter T, Pomej K, Simbrunner B, Semmler G, Trauner M, Mandorfer M, Reiberger T. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease. Liver Int 2020;40:2797-807. [PMID: 32816394 DOI: 10.1111/liv.14648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
3 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases. In Vivo. 2020;34:2561-2569. [PMID: 32871785 DOI: 10.21873/invivo.12073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. Int J Mol Sci. 2020;21:5254. [PMID: 32722100 DOI: 10.3390/ijms21155254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
5 Santos BC, Ferreira LG, Ribeiro HS, Correia MITD, Lima AS, Penna FGCE, Anastácio LR. Bioelectrical impedance vector analysis in patients on the waiting list for liver transplant: Associated factors and prognostic effects. Nutrition 2021;94:111528. [PMID: 34891107 DOI: 10.1016/j.nut.2021.111528] [Reference Citation Analysis]
6 Woolfson JP, Perez M, Chavhan GB, Johara FT, Lurz E, Kamath BM, Ng VL. Sarcopenia in Children With End-Stage Liver Disease on the Transplant Waiting List. Liver Transpl 2021;27:641-51. [PMID: 33460522 DOI: 10.1002/lt.25985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
7 Kim Y. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:250. [PMID: 33803020 DOI: 10.3390/life11030250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F. Secondary Osteoporosis. Endocr Rev 2021:bnab028. [PMID: 34476488 DOI: 10.1210/endrev/bnab028] [Reference Citation Analysis]
9 Lai RM, Chen TB, Hu YH, Wu G, Zheng Q. Effect of type 2 diabetic mellitus in the prognosis of acute-on-chronic liver failure patients in China. World J Gastroenterol 2021; 27(23): 3372-3385 [PMID: 34163118 DOI: 10.3748/wjg.v27.i23.3372] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Duong N, Sadowski B, Rangnekar AS. The Impact of Frailty, Sarcopenia, and Malnutrition on Liver Transplant Outcomes. Clin Liver Dis (Hoboken) 2021;17:271-6. [PMID: 33968388 DOI: 10.1002/cld.1043] [Reference Citation Analysis]
11 Kamo N, Kaido T, Uozumi R, Ito T, Yagi S, Hata K, Taura K, Uemoto S. Effect of administration of β-hydroxy-β-methyl butyrate-enriched formula after liver transplantation: A pilot randomized controlled trial. Nutrition 2020;79-80:110871. [PMID: 32593895 DOI: 10.1016/j.nut.2020.110871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Ooi PH, Mazurak VC, Bhargava R, Dunichand‐hoedl A, Ayala Romero R, Gilmour SM, Yap JY, Mager DR. Myopenia and Reduced Subcutaneous Adiposity in Children With Liver Disease Are Associated With Adverse Outcomes. Journal of Parenteral and Enteral Nutrition 2021;45:961-72. [DOI: 10.1002/jpen.1963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Jobber CJD, Wilkinson SA, Hughes EK, Nave F, van der Meij BS. Using the theoretical domains framework to inform strategies to support dietitians undertaking body composition assessments in routine clinical care. BMC Health Serv Res 2021;21:518. [PMID: 34049555 DOI: 10.1186/s12913-021-06375-7] [Reference Citation Analysis]
14 Santos BC, Fonseca ALF, Ferreira LG, Ribeiro HS, Correia MITD, Lima AS, Penna FGCE, Anastácio LR. Different combinations of the GLIM criteria for patients awaiting a liver transplant: Poor performance for malnutrition diagnosis but a potentially useful prognostic tool. Clin Nutr 2021;41:97-104. [PMID: 34864459 DOI: 10.1016/j.clnu.2021.11.008] [Reference Citation Analysis]
15 Kikuchi N, Uojima H, Hidaka H, Iwasaki S, Wada N, Kubota K, Nakazawa T, Shibuya A, Fujikawa T, Kako M, Sato T, Koizumi W. Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology. Hepatol Res 2021;51:968-78. [PMID: 34269502 DOI: 10.1111/hepr.13698] [Reference Citation Analysis]
16 Wang T, Yang X, Wang W, Chen T, Kong J, Shen S, Chen Y, Wei G, Yu D, Wang C, Li M, Rui S, Luo B, Wang W. A new sarcopenia score prognostic for postoperative complications in hepatic alveolar echinococcosis: a multicenter retrospective study. Ann Transl Med 2020;8:1398. [PMID: 33313143 DOI: 10.21037/atm-20-1960a] [Reference Citation Analysis]
17 Boillot O, Cayot B, Guillaud O, Crozet-Chaussin J, Hervieu V, Valette PJ, Dumortier J. Partial major hepatectomy with cyst fenestration for polycystic liver disease: Indications, short and long-term outcomes. Clin Res Hepatol Gastroenterol 2021;45:101670. [PMID: 33722781 DOI: 10.1016/j.clinre.2021.101670] [Reference Citation Analysis]
18 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:86. [PMID: 33504046 DOI: 10.3390/life11020086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Qayyum A, Bhosale P, Aslam R, Avritscher R, Ma J, Pagel MD, Sun J, Mohamed Y, Rashid A, Beretta L, Kaseb AO. Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:1008-15. [PMID: 32974761 DOI: 10.1007/s00261-020-02751-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Feng H, Wang X, Zhao T, Mao L, Hui Y, Fan X, Lin L, Zhao W, Jiang K, Wang B, Yu Q, Zhang J, Sun C. Myopenic obesity determined by visceral fat area strongly predicts long-term mortality in cirrhosis. Clin Nutr 2021;40:1983-9. [PMID: 32977996 DOI: 10.1016/j.clnu.2020.09.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease.Life (Basel). 2021;11. [PMID: 33504046 DOI: 10.3390/life11020086.] [Reference Citation Analysis]
22 Woolfson JP, Kamath BM, Ng VL. Reply. Liver Transpl 2021;27:1073-4. [PMID: 33715281 DOI: 10.1002/lt.26051] [Reference Citation Analysis]
23 Ayorinde T, Panayotova G, Sharma A, Lunsford KE. Clinical and biomarker assessment of frailty in liver transplantation. Curr Opin Organ Transplant 2021. [PMID: 34343156 DOI: 10.1097/MOT.0000000000000911] [Reference Citation Analysis]
24 Grutters LA, Pennings JP, Bruggink JL, Viddeleer AR, Verkade HJ, de Kleine RH, de Haas RJ. Body Composition of Infants With Biliary Atresia: Anthropometric Measurements and Computed Tomography-based Body Metrics. Journal of Pediatric Gastroenterology & Nutrition 2020;71:440-5. [DOI: 10.1097/mpg.0000000000002859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
25 Dunn MA, Rogal SS, Duarte-Rojo A, Lai JC. Physical Function, Physical Activity, and Quality of Life After Liver Transplantation. Liver Transpl 2020;26:702-8. [PMID: 32128971 DOI: 10.1002/lt.25742] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
26 Hou L, Deng Y, Wu H, Xu X, Lin L, Cui B, Zhao T, Fan X, Mao L, Hou J, Sun H, Wang B, Sun C. Low psoas muscle index associates with long-term mortality in cirrhosis: construction of a nomogram. Ann Transl Med 2020;8:358. [PMID: 32355802 DOI: 10.21037/atm.2020.02.49] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Ye Q, Cai JJ, Yan JQ, Lv R. Role of L3-PMI in prognostic evaluation of patients with acute-on-chronic liver failure related to hepatitis B cirrhosis. Shijie Huaren Xiaohua Zazhi 2021; 29(20): 1167-1173 [DOI: 10.11569/wcjd.v29.i20.1167] [Reference Citation Analysis]
28 Sun T, Wang T, Qiu Y, Shen S, Yang X, Yang Y, Huang B, Wang W. A Sarcopenia-Based Prediction Model for Postoperative Complications of ex vivo Liver Resection and Autotransplantation to Treat End-Stage Hepatic Alveolar Echinococcosis. Infect Drug Resist 2021;14:4887-901. [PMID: 34848980 DOI: 10.2147/IDR.S340478] [Reference Citation Analysis]
29 Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S. Walking Speed: Japanese Data in Chronic Liver Diseases. J Clin Med. 2020;9:166. [PMID: 31936162 DOI: 10.3390/jcm9010166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
30 Raghu VK, Sico R, Rudolph JA, Mazariegos GV, Squires J, Squires JE. Sarcopenia prevalence in pediatric intestinal transplant recipients: Implications on post‐transplant outcomes. Pediatric Transplantation. [DOI: 10.1111/petr.14256] [Reference Citation Analysis]
31 Ooi PH, Mazurak VC, Siminoski K, Bhargava R, Yap JYK, Gilmour SM, Mager DR. Deficits in Muscle Strength and Physical Performance Influence Physical Activity in Sarcopenic Children After Liver Transplantation. Liver Transpl 2020;26:537-48. [PMID: 31965696 DOI: 10.1002/lt.25720] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
32 Verhagen MV, Levolger S, Hulshoff JB, Werner MJM, van der Doef HPJ, Viddeleer AR, de Kleine RH, de Haas RJ. Utility of Preoperative Computed Tomography-Based Body Metrics in Relation to Postoperative Complications in Pediatric Liver Transplantation Recipients. Liver Transpl 2021. [PMID: 34118133 DOI: 10.1002/lt.26205] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Dhaliwal A, Armstrong MJ. Sarcopenia in cirrhosis: A practical overview. Clin Med (Lond) 2020;20:489-92. [PMID: 32934043 DOI: 10.7861/clinmed.2020-0089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Czigany Z, Kramp W, Lurje I, Miller H, Bednarsch J, Lang SA, Ulmer TF, Bruners P, Strnad P, Trautwein C, von Websky MW, Tacke F, Neumann UP, Lurje G. The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation. J Cachexia Sarcopenia Muscle 2021;12:358-67. [PMID: 33525056 DOI: 10.1002/jcsm.12669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Rozynek M, Kucybała I, Urbanik A, Wojciechowski W. Use of artificial intelligence in the imaging of sarcopenia: A narrative review of current status and perspectives. Nutrition 2021;89:111227. [PMID: 33930789 DOI: 10.1016/j.nut.2021.111227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Sung YS, Park B, Park HJ, Lee SS. Radiomics and deep learning in liver diseases. J Gastroenterol Hepatol 2021;36:561-8. [PMID: 33709608 DOI: 10.1111/jgh.15414] [Reference Citation Analysis]
37 Miarka M, Gibiński K, Janik MK, Główczyńska R, Zając K, Pacho R, Raszeja-Wyszomirska J. Sarcopenia-The Impact on Physical Capacity of Liver Transplant Patients. Life (Basel) 2021;11:740. [PMID: 34440484 DOI: 10.3390/life11080740] [Reference Citation Analysis]
38 Metzger GA, Sebastião YV, Carsel AC, Nishimura L, Fisher JG, Deans KJ, Minneci PC. Establishing Reference Values for Lean Muscle Mass in the Pediatric Patient. J Pediatr Gastroenterol Nutr 2021;72:316-23. [PMID: 33003166 DOI: 10.1097/MPG.0000000000002958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
39 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points. In Vivo 2020;34:2549-59. [PMID: 32871784 DOI: 10.21873/invivo.12072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Guirguis RN, Nashaat EH, Yassin AE, Ibrahim WA, Saleh SA, Bahaa M, El-Meteini M, Fathy M, Dabbous HM, Montasser IF, Salah M, Mohamed GA. Impact of biliary complications on quality of life in live-donor liver transplant recipients. World J Hepatol 2021; 13(10): 1405-1416 [PMID: 34786175 DOI: 10.4254/wjh.v13.i10.1405] [Reference Citation Analysis]
41 Villeret F, Dumortier J, Erard-Poinsot D. How will NAFLD change the liver transplant landscape in the 2020s? Clin Res Hepatol Gastroenterol 2021;:101759. [PMID: 34311133 DOI: 10.1016/j.clinre.2021.101759] [Reference Citation Analysis]
42 Lurz E, Patel H, Lebovic G, Quammie C, Woolfson JP, Perez M, Ricciuto A, Wales PW, Kamath BM, Chavhan GB, Jüni P, Ng VL. Paediatric reference values for total psoas muscle area. J Cachexia Sarcopenia Muscle 2020;11:405-14. [PMID: 31920002 DOI: 10.1002/jcsm.12514] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
43 van der Meij BS, Mazurak VC. Fish oil supplementation and maintaining muscle mass in chronic disease: state of the evidence. Curr Opin Clin Nutr Metab Care 2020;23:164-73. [PMID: 32167986 DOI: 10.1097/MCO.0000000000000648] [Reference Citation Analysis]
44 Mauro E, Crespo G, Martinez-Garmendia A, Gutierrez-Acevedo MN, Diaz JM, Saidman J, Bermudez C, Ortiz-Patron J, Garcia-Olveira L, Zalazar F, Narvaez A, Spina JC, Orta R, Savluk L, Piano S, Marciano S, Gadano A. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List. Transplantation. 2020;104:e188-e198. [PMID: 32150034 DOI: 10.1097/tp.0000000000003222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
45 Lee DU, Fan GH, Hastie DJ, Prakasam VN, Addonizio EA, Ahern RR, Seog KJ, Karagozian R. The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data. J Clin Exp Hepatol 2021;11:531-43. [PMID: 34511813 DOI: 10.1016/j.jceh.2021.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]